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Abstract
The cell cycle is tightly controlled to ensure that replication origins fire only once per cycle and
that consecutive S-phases are separated by mitosis. When controls fail, DNA over-replication
ensues: individual origins fire more than once per S-phase (re-replication) or consecutive S-phases
occur without intervening mitoses (endoreduplication). In yeast the cell cycle is controlled by a
single cyclin dependent kinase (Cdk) that prevents origin licensing at times when it promotes origin
firing, and that is inactivated, via proteolysis of its partner cyclin, as cells undergo mitosis. A
quantitative model describes three levels of Cdk activity: low activity allows licensing, intermediate
activity allows firing but prevents licensing, and high activity promotes mitosis. In higher eukaryotes
the situation is complicated by the existence of additional proteins (geminin, Cul4-Ddb1Cdt2, and
Emi1) that control licensing. A current challenge is to understand how these various control
mechanisms are co-ordinated and why the degree of redundancy between them is so variable. Here
the experimental induction of DNA over-replication is reviewed in the context of the quantitative
model of Cdk action. Endoreduplication is viewed as a consequence of procedures that cause Cdk
activity to fall below the threshold required to prevent licensing, and re-replication as the result of
procedures that increase that threshold value. This may help to explain why over-replication does
not necessarily require reduced Cdk activity and how different mechanisms conspire to prevent
over-replication. Further work is nevertheless required to determine exactly how losing just one
licensing control mechanism often causes over-replication, and why this varies between cell
systems.
Background
DNA over-replication: the result of uncontrolled origin 
licensing
The two main hallmarks of the eukaryotic cell cycle are the
duplication of the genome (S-phase) and segregation of
the two resulting copies into two progeny cells (mitosis).
In the interests of genome stability, S-phases must alter-
nate with mitoses and must exactly duplicate the genome.
Genome duplication involves DNA replication starting at
multiple origins, each of which must therefore initiate
('fire') only once per S-phase, and only if preceded by
mitosis. To achieve this an origin licensing system has
evolved: origins cannot fire without being licensed, and
then cannot be re-licensed without passing through mito-
sis, during which conditions permissive for licensing but
not firing are restored [1-3]. Biochemically, licensing
refers to the combined action of various factors (ORC,
cdc6, Cdt1, MCM2-7) in assembling a pre-replication
complex at replication origins, a process that occurs in G1
prior to origin firing in S-phase.
Failures in licensing control can give rise to two basic
types of DNA over-replication: endoreduplication and re-
replication. (The terminology of Arias and Walter [4] is
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used here, but it should be noted that in many publica-
tions, the term re-replication is used more broadly to
encompass both re-replication and endoreduplication).
In endoreduplication, S-phase is no longer dependent on
the passage through mitosis and multiple consecutive S-
phases can occur (Fig. 1a,b,c) giving rise to discrete
increases in DNA content; within a single S-phase, how-
ever, origins still fire only once. Endoreduplication occurs
naturally in certain cell types as part of their normal devel-
opmental programme [5]. In contrast, re-replicating cells
no longer maintain the temporal separation of origin
licensing and firing. Thus, during re-replication, origins
can fire more than once within a single S-phase leading to
a continuous increase in DNA content (Fig. 1d). Re-repli-
cation does not appear to occur as part of any natural
developmental programme. Experimentally, endoredu-
plication (at least from G2 or M) and re-replication are
usually distinguished by flow cytometric measurements
of DNA content, the former giving rise to discrete peaks
corresponding to 8 N, 16 N, 32 N etc. (N = haploid chro-
mosome number), the latter generating a range of DNA
contents with intermediate values (e.g. between 4 N and 8
N). Endoreduplication from S-phase is also expected to
generate intermediate values and so is probably difficult
to distinguish from re-replication by this method. Dis-
crete doublings in ploidy do not necessarily indicate
endoreduplication; they can also result from failures in
cytokinesis (Fig. 1e), but these involve no change in
licensing control and will not be considered further here.
Cdk and APC/C: mutually antagonistic drivers of the cell 
cycle
The master controllers of the cell cycle are the cyclin
dependent kinases [6,7] and the anaphase promotion/
cyclosome (APC/C) complex [8,9]. When heterodimer-
ised with their cyclin partners, which are periodically
degraded at various points during the cell cycle, Cdks pro-
mote both S-phase and mitosis by phosphorylating key
target proteins. The single Cdk in fission and budding
yeast (Cdc2 and Cdc28 respectively; hereafter Cdk1) asso-
ciates with multiple cyclins but, at least in fission yeast, a
viable cell cycle can be supported by a single cyclin [10].
In budding yeast, cells with deletions in all six B-type cyc-
lin genes [11] or in all three G1-type cyclin genes [12] can
be rescued by expression of a single B-type cyclin gene.
In higher eukaryotes multiple Cdks and cyclins exist, the
key combinations being Cdk1/cyclin A and B at mitosis,
Cdk1 and 2/cyclin A and E during G1/S and Cdk4 and 6/
cyclin D during G1 [6]. While different Cdk/cyclin combi-
nations are required in specific lineages during develop-
ment, accumulating evidence [13-18], particularly the
recent generation of viable mouse embryo fibroblasts
(MEFs) deleted for Cdk2, Cdk4 and Cdk6 [19], indicates
that Cdk1 is the only major Cdk that is absolutely
required for viable cell cycles. Furthermore, in frog egg
extracts mitotic cyclins are capable of supporting S-phase
functions [20,21], and the major cyclin genes can be indi-
vidually deleted in mice without completely preventing
cell proliferation [22]. It has yet to be determined, how-
ever, whether higher eukaryotes can, like fission yeast,
support viable cell cycles with just a single cyclin/Cdk1
combination.
The counterbalance to Cdk activity is provided by the
APC/C, a ubiquitin ligase complex which has many sub-
strates but most crucially targets mitotic cyclins at ana-
phase for degradation [8,9]. This effectively eliminates
Cdk activity, allowing for a period (late M and G1) that is
permissive for origin licensing. For the rest of the cell cycle
(S, G2 and early M) APC/C must be inactivated, so that
mitotic cyclins (A and B) can re-accumulate, and this is
achieved (at least in part; see below) by inhibitory, Cdk-
mediated phosphorylation of Cdh1, the G1 activating
subunit of APC/C. During mitosis, however, high Cdk1
activity activates another APC/C activator, Cdc20, leading
to the destruction of mitotic cyclins that allows mitotic
exit and activation of APC/CCdh1. APC/C and Cdk are thus
Pathways of over-replication Figure 1
Pathways of over-replication. The G1 state required for 
coordinated origin licensing is normally reached by passing 
through mitosis. Endoreduplicating cells reach G1 from early 
M (a), G2 (b) or S (c). Re-replication (d) involves a continu-
ous S-phase during which origin licensing and firing are both 
permitted. Endomitosis (e) occurs when cytokinesis (CyK) is 
bypassed but does not involve premature licensing. This fig-
ure is similar to Fig. 3 in [5] describing naturally occurring 
endoreduplication. Pro, Met, Ana, Tel refer to prophase, 
metaphase, anaphase and telophase, respectively.
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mutually antagonistic and the cell cycle oscillates between
periods dominated by APC/C or Cdk activity.
DNA over-replication and the quantitative model of Cdk 
action in yeast
In addition to its roles in promoting S phase and mitosis,
Cdk has a third role: preventing DNA over-replication.
This role was revealed in fission yeast when a temperature
sensitive Cdk1 allele was transiently heat-inactivated after
G2 arrest, causing the cells to bypass mitosis, to 'reset' in
G1 and undergo a second S-phase [23]. Furthermore,
multiple consecutive S-phases could be induced by dele-
tion of Cdc13 [24], which encodes the mitotic cyclin part-
ner of Cdk1, or by over-expression or Rum1 [25,26], an
inhibitor of Cdk1 in G2. Such endoreduplication was
demonstrated by discrete doublings in the genome size.
Similar results were obtained in budding yeast [27].
The problem of how a single Cdk could suppress over-rep-
lication yet also promote S-phase and M-phase was
addressed in the quantitative model of Cdk action
[10,28]. It was proposed that, following exit from mitosis,
rising levels of Cdk activity pass through two thresholds.
Below the first threshold (TS), in G1, replication origins
can be licensed but cannot fire, but above TS origins can
fire but cannot be re-licensed. Thus transition above TS
marks the beginning of S-phase and ensures that origins
fire only once per S-phase. The second threshold (TM) is
passed when inhibitory phosphorylation sites on Cdk1
are removed by Cdk1-activated Cdc25 phosphatase,
resulting in a highly activated Cdk1 that promotes the
onset of mitosis [29]. Destruction of mitotic cyclins by the
APC/C allows mitotic exit and completes the cycle (Fig.
2A).
Although the quantitative model is strongly supported by
the observation that a single cyclin/Cdk1 complex can
guide the cell cycle of fission yeast [10], a degree of quali-
tative control is also evident. Thus, individual cyclin/Cdk
combinations are known to have specific functions
[3,30,31] and these are likely to contribute to the fine tun-
ing of cell cycle control, especially in higher vertebrates.
Endoreduplication is explained in the context of the
quantitative model as follows (Fig. 2B,C). In G2, or early
M, experimental depletion of Cdk activity causes prema-
ture activation of APC/CCdh1, without the need to traverse
mitosis and activate APC/CCdc20. The cells therefore reset
in G1, co-ordinately relicense all origins and, when Cdk is
reactivated, enter the next S-phase. For multiple endocy-
cles, the loss of Cdk activity must be repeated each time
the cells reach G2/M. This can be achieved experimentally,
(e.g. by repeated temperature shifts in tsCdk1 mutants) or
spontaneously, by residual cell cycle oscillations. Thus,
multiple endocycles seen after Cdc13 deletion in fission
yeast reflect the periodic synthesis and inactivation of the
S-phase cyclins. In principle, those cells in S-phase at the
time of Cdk1 depletion should also reset in G1 (Fig 2D),
in which case restoration of Cdk1 activity would lead to
duplication of a partially replicated genome, i.e. discrete
but variable increases in ploidy to less than 8 N. This form
of endoreduplication does not appear to have been
described after the experimental depletion of Cdk1 activ-
ity, possibly because of difficulties in distinguishing it on
the basis of DNA content from other forms of over-repli-
cation, but it does occur naturally in Drosophila larval tis-
sue [5].
To describe re-replication in terms of the quantitative
model it is important to remember that, by definition, it
involves conditions that simultaneously permit both ori-
gin licensing and firing. Multiple overlapping mecha-
nisms by which Cdk1 can prevent origin licensing in yeast
have been revealed. These include inhibition of ORC,
nuclear export of Cdt1 and MCM2-7, and inactivation,
degradation and reduced synthesis of Cdc6 ([32]; see [4]
for a recent review). More recently the essential Cdk1 sub-
strates (Sld2, Sld3) whose phosphorylation leads to origin
firing have been identified [33]. These studies do not
appear to indicate that the threshold Cdk activities for
inhibiting origin licensing (TL) and for promoting origin
firing (TF) need necessarily coincide. The possibility there-
fore exists that these are independent thresholds and that,
under normal circumstances, parameters are set such that
TF > TL. In this model, re-replication is caused by any pro-
cedure that disturbs such parameters to cause TF < TL (Fig.
2E). In budding yeast, multiple components of the preRC
complex are sensitive to Cdk1 phosphorylation and so
conspire to keep TL low, but when enough of the relevant
phosphorylation sites are mutated, re-replication follows
[32]. Alternatively, modifications to Sld2 and Sld3 that
remove their dependence on phosphorylation by Cdk1,
effectively reduce the value of TF and so cause re-replica-
tion [33].
This proposed separation of TS into separate thresholds
(TF and TL) has the additional attraction that it predicts an
'insulation' period at the G1/S transition, and also at ana-
phase, during which origins can neither be licensed nor
fire, ensuring that there is no overlap between periods of
origin licensing and firing (Fig. 2F). Although insulation
in budding yeast has been elegantly explained in terms of
different cyclin specificities [3], this quantitative model is
potentially more appropriate in fission yeast, at least,
where viable cycles require only a single Cdk/cyclin com-
bination.
How far can these descriptions of endoreduplication and
re-replication in yeast be applied in mammalian cells?Cell Division 2008, 3:3 http://www.celldiv.com/content/3/1/3
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Endoreduplication from G2 or M after Cdk1 inactivation 
in mammalian cells
By analogy with the work in yeast, experimental depletion
of Cdk1 in higher eukaryotes might be expected to pro-
mote endoreduplication and this is indeed the case in
some cell lines. Thus endoreduplication was seen in
human fibrosarcoma cells (HT2-19) with repressible
Cdk1 gene expression [34] and in human osteosarcoma
(U2OS) cells depleted of Cdk1 by RNA interference [35].
Because Cdk1 depletion was sustainable in these studies,
it was possible to detect multiple endocycles, generating
ploidies as high as 64 N. (In contrast to yeast, multiple
endocycles do not require multiple transient Cdk1 inacti-
vations because S-phases do not require Cdk1.) These
endocycles apparently correspond to endoreduplication
from G2 (Fig. 2C), bypassing mitosis but maintaining
normal S-phases. Thus endoreduplicating HT2-19 cells do
not undergo nuclear envelope breakdown or activate the
Quantitative model of Cdk activity applied to normal and over-replicating cell cycles Figure 2
Quantitative model of Cdk activity applied to normal and over-replicating cell cycles. Cdk (continuous line) and 
APC/C (broken line) activities (y-axis) are plotted against time (x-axis). TM, TS, TL and TF indicate thresholds of Cdk activity, as 
defined in the text. P,M,A,T and C: prometaphase, metaphase, anaphase telophase and cytokinesis, respectively. A. Normal 
cycle. B. Endoreduplication from mitosis. C. Endoreduplication from G2. D. Endoreduplication from S-phase. E. Re-replication. 
F. Normal cell cycle with periods of insulation (white segments) when origins can neither be licensed nor fire. Fire +/- = suffi-
cient/insufficient Cdk to promote origin firing. License +/- = sufficient/insufficient Cdk to prevent licensing.
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APC/CCdc20, but retain cycles of cyclin E expression and
centrosome duplication [36]. Also consistent with the
model in Fig. 2C is the ability of Cdk1 that lacks inhibi-
tory phosphorylation sites, and is therefore unresponsive
to Cdc25 phosphatase, to prevent endoreduplication in
HT2-19 without promoting mitosis [37].
Endoreduplication is sometimes seen after DNA damage
and this may also be explained in terms of reduced Cdk1
activity [38]. Although G2 checkpoint pathways are
known to prevent Cdk1 activation by preventing the
removal of inhibitory phosphorylations [39], this is only
predicted to prevent Cdk1 levels from exceeding the TM
threshold, and so to prevent mitosis. However, suffi-
ciently intense or sustained levels of DNA damage can
cause transcriptional silencing of various genes expressed
in S/G2, including Cdk1 [38,40], and this more easily
explains DNA damage-induced endoreduplication. Cdt1
is also degraded in response to DNA damage by the Cdk-
independent Cul4-Ddb1Cdt2 pathway ([4];see below) and
this effect is presumably lost in cells that over-replicate in
response to DNA damage.
Endoreduplication has also been observed (in SaOS cells)
after indirectly depleting Cdk1 activity with high levels of
the Cdk inhibitors p21 or p27 [41,42] or (in HCT-116
cells) with siRNA to cyclin B [43]. Endoreduplication in
response to Cdk inhibitor over-expression was found to
occur in cells (SaOS, HeLa and in Rb-/-MEFs) lacking
functional Retinoblastoma protein (Rb) but not in con-
trol cells (Rb+/-MEFs, RKO, Rat1, A549, H1299, HaCat,
SW480) with a functional Rb [41]. This is expected if
endoreduplicating cells reset in G1 because Cdk inhibi-
tion at this stage would prevent the Rb phosphorylation
required to release the E2F transcription factor necessary
for the G1/S transition. Cyclin B-depleted HCT116 cells
still show signs of early mitosis, presumably due to Cdk1/
cyclin A activity, but they exit mitosis before metaphase
[43].
In some studies, involving NCI-H1299 [35] or HeLa and
HePG2 cells [44], appreciable endoreduplication required
depletion of both cyclin A and B, or both Cdk1 and Cdk2.
There is evidence that Cdk2/cyclinA can promote Cdk1
activation [45] and this may help to explain the enhanced
phenotype after cyclin A depletion. It is less easy to
explain how depleting Cdk2 activity, including Cdk2/
cyclinA, can promote endoreduplication when it is essen-
tial for origin firing in the absence of Cdk1. It is possible,
however, that Cdk4 or Cdk6 can substitute for Cdk2 at
G1/S, as Cdk1 is capable of doing [14,46]. Alternatively,
depletion of cyclin A or Cdk2 in these studies may have
been more effective at inactivating Cdk1 than Cdk2.
It is notable than in none of the above studies was there
any clear evidence of re-replication i.e. of partial rather
than discrete increases in ploidy. This is consistent with
the models of Fig. 2 because changes in Cdk activity are
not predicted to alter the values TF and TL. However, par-
tial increases in ploidy might have been expected if
endoreduplication had been induced from S-phase, sug-
gesting that other pathways prevent endoreduplication
during S-phase.
There are several mechanisms by which Cdk activity may
inhibit origin licensing (reviewed in [4]). The clearest
seems to be degradation of Cdt1 by the SCFSkp2 pathway
in response to its phosphorylation by Cdk, particularly in
G2 [47,48]. Also there are data to suggest that the binding
of Cdt1 [49,50], ORC and cdc6 [51-54] may each be sub-
ject to control by Cdk activity. If sufficient Cdk target sites
in the licensing machinery can be mutated, this would be
expected to increase the value of TL and induce re-replica-
tion, but only if Cdk-independent mechanisms of inhibit-
ing licensing are also inactivated (see below). The
importance of Cdt1 and Cdc6 as targets for the control of
re-replication was demonstrated by the re-replication seen
when Cdt1 and Cdc6 were over-expressed in H1299 cells
[55].
Cells that do not over-replicate after Cdk1 inactivation
Contrasting with the above studies are reports of cell lines
where Cdk1 depletion does not result in over-replication.
Thus Cdk1 depletion by siRNA failed to induce over-rep-
lication in NCI-H1299 cells [35], although as already
mentioned, co-depletion of Cdk2 induced endoreduplica-
tion. FT210 cells, whose endogenous Cdk1 protein is tem-
perature-sensitive, arrested in G2 at non-permissive
temperature; no over-replication was seen 20 h after tem-
perature-shift [56], but it would be interesting to know the
situation at later times. Similarly, chemical inhibition of
Cdk1 in asynchronous cultures of HeLa, SW480 or
HCT116 cells for 20 h [57], or DT40 cells for 48 h [18],
caused only a G2 arrest. In all these cell lines, however,
including FT210, Cdk1 inactivation after presynchronisa-
tion in mitosis by treatment with nocodazole, did lead to
endoreduplication. Thus, in these cell lines, Cdk1 appears
to be alone in suppressing endoreduplication during early
mitosis, but not in G2. A formal, and potentially interest-
ing explanation for why endoreduplication from G2 is
seen after Cdk1 depletion but not after chemical inactiva-
tion, would arise if a kinase-independent property of
Cdk1 were capable of suppressing endoreduplication in
G2. The results in FT210 cells, where Cdk1 is degraded at
the non-permissive temperature, argue against this, and a
less radical explanation involving Emi1 has recently
emerged (see below). Nevertheless, a direct comparison in
the same cells of the effects of Cdk1 depletion and inhibi-
tion would be valuable. Whatever the outcome, theseCell Division 2008, 3:3 http://www.celldiv.com/content/3/1/3
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results indicate that, in several cell lines, Cdk1 activity is
not alone in being able to suppress licensing in inter-
phase, a conclusion that has been reached by several other
lines of investigation.
Geminin and Cul4-Ddb1Cdt2 suppress over-replication by 
regulating Cdt1
Geminin is a protein present in metazoans, but not in
yeast, that suppresses origin licensing through its ability to
bind and inactivate Cdt1 [58,59]. Geminin is stable dur-
ing S, G2 and early M, but targeted for degradation by
APC/C and therefore degraded during mitosis, allowing
for origin licensing until it is resynthesised in late G1. Two
pathways target Cdt1 for degradation. The Cul4-Ddb1Cdt2
pathway requires Cdt1 to interact with PCNA and there-
fore operates only in S-phase, but is apparently independ-
ent of Cdk activity. This contrasts with Cdt1 degradation
by SCFSkp2, which operates mainly in S/G2/M and, as
mentioned above, depends on phosphorylation of Cdt1
by Cdk1. By reducing the amount of free Cdt1, these
mechanisms both effectively reduce the level of Cdk activ-
ity required to suppress licensing, i.e. reduce the value of
TL, during S, G2 and early mitosis. Initially these mecha-
nisms may have evolved to further reduce the chances of
premature re-licensing and to improve the 'insulation'
during transitions between phases of high Cdk1 activity
and high APC/C activity. Over time, however, mamma-
lian cells have apparently become dependent on them to
ensure that TL< TF. Thus, depletion of geminin (in S/G2/
M) or Cdt2 (in S) may be sufficient to raise the value of TL
above that for TF and so cause re-replication. Accordingly,
depletion of geminin in HCT116, U2OS and TIG3 cells
[60-62], and Cdt2 [63]or Ddb1 [64] in HeLa cells, all
cause over-replication characterised by the partial
increases in ploidy expected for re-replication. Geminin
depletion in HeLa and MCF10A cells does not cause over-
replication [60,65,66], however, suggesting that the Cul4-
Ddb1Cdt2 pathway plays the predominant role in these
cells during S phase. In mouse embryos, geminin down-
regulation is associated with endoreduplication and the
formation of polyploid cells of the trophoblast lineage
[67], rather than with re-replication, suggesting that other
pathways prevent licensing during S-phase.
Interestingly, over-replication (apparently involving a mix
of partial and discrete increases in ploidy) is seen after
geminin depletion in HeLa cells if cyclin A is also depleted
(cyclin A depletion alone causing very modest endoredu-
plication)[60]. It is also notable that in cases where over-
replication was caused by geminin or Cdt2 depletion it
was less pronounced when DNA damage-induced check-
points that lead to Cdk1 inactivation were blocked with
caffeine [61,62]. A possible explanation for these observa-
tions is that in some cells, even when TL> TF, Cdk activity
must be limited so that it stays between these two thresh-
old values in order for appreciable re-replication to occur.
The question remains, however, of why the Cul4-
Ddb1Cdt2 pathway in HeLa cells, whose inhibition is suffi-
cient to cause re-replication [63,64], does not prevent re-
replication after the combined depletion of geminin and
cyclin A[60]. The possibility should be considered, there-
fore, that the over-replication caused by depleting both
geminin and cyclin A is primarily endoreduplication and
that apparent partial increases in ploidy reflect a second-
ary phenomenon (e.g. apoptosis) and not re-replication.
While the roles of geminin and the Cul4-Ddb1Cdt2 path-
way in suppressing licensing clearly overlap with the role
of Cdk1, there are difficulties in explaining how they
could be responsible for suppressing origin licensing in
those cases where Cdk1 depletion does not cause endore-
duplication. This is because Cdk1 depletion is expected to
result in APC/C activation, at least in G2/M, and therefore
geminin degradation, while the Cul4-Ddb1Cdt2 pathway
only operates in S-phase. The solution to this problem
appears to lie with Emi1.
Emi1 suppresses over-replication by inhibiting APC/C
Just as the role of Cdk in suppressing licensing is sup-
ported by the actions of geminin and the Cul4-Ddb1Cdt2
pathway, so its role in suppressing APC/C during S and G2
is assisted by Emi1. Emi1 is an APC/C inhibitor that inter-
acts with Cdc20 [68] and Cdh1 [69,70]. It is synthesised
when the transcription factor E2F is activated at the G1/S
boundary [69]and degraded by SCF-dependent proteoly-
sis early in mitosis promoted by Plk1[71]. Emi1 therefore
keeps APC/CCdh1 inactive during S and G2, allows mitotic
cyclins and geminin to accumulate. In two recent studies
where Emi1 was depleted by siRNA in MCF10A, HCT116
and HeLa cells, over-replication was observed, accompa-
nied by reduced levels of cyclins A and B1 and geminin
[60,72].
This newly established role for Emi1 may help to explain
the different responses between cell lines to Cdk1 inacti-
vation. In some cell lines Emi1 may be sufficiently abun-
dant or available to prevent APC/C activation during S/
G2, even when Cdk1 is inactive. For example, it was only
in mitosis, when Emi1 is degraded, that Cdk1 inhibition
caused endoreduplication in various cell lines [18,57]. In
G2, despite Cdk1 inactivation, geminin was stable and
APC/C remained inactive [18]. In others cell lines, such as
HT1080, however, Emi1 presumably plays a less decisive
role than Cdk1 in preventing APC/C activation because
Cdk1 depletion causes endoreduplication from G2
[34,35]. Further work is required to test the validity of this
explanation and to determine the basis of any differences
in Emi1 function between cell lines.Cell Division 2008, 3:3 http://www.celldiv.com/content/3/1/3
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The over-replication seen after Emi1 depletion in HeLa
and HCT116 cells appears mainly to involve partial
increases in ploidy, suggestive of re-replication [60,72].
This is somewhat puzzling because activation of APC/C
following Emi1 depletion is expected to reset cells in a G1-
like state and so cause endoreduplication. Also, in HeLa
cells at least, the Cul4-Ddb1Cdt2 pathway should be capa-
ble of preventing origin licensing in S-phase, and there-
fore re-replication. The phenotype in Emi1-depleted
MCF10A is more suggestive of endoreduplication [60],
however, and it will be interesting to characterise in more
detail, and in more cells lines (including non-transformed
cells), the nature of the over-replication caused by Emi1
depletion.
Overview of over-replication control
The key factors that regulate origin licensing and therefore
DNA over-replication at various stages of the vertebrate
cell cycle are summarised in Fig. 3. The central role of Cdk
is evident, involving not only its ability to inhibit APC/
Cdh1 but also the licensing machinery. It can also be seen
how APC/C (and therefore Emi1) is crucial in licensing
control because of its role in depleting both geminin and,
via cyclin degradation, Cdk1/2 activity [73]. Thus we can
see how depleting Cdk activity in mitosis (and in G2 if
Emi1 is inactive), or promoting APC/CCdh1 activity, can
cause endoreduplication by reprogramming cells into a
G1-like state without the need to pass through mitosis.
Less clear from this summary is how altering just one of
the multiple mechanisms for licensing inhibition so often
leads to re-replication, and how this can differ between
cell lines. The simplest explanation is perhaps that differ-
ent inhibitory mechanisms contribute unequally and that
the balance of contributions is 'set' differently in different
cell lines. The example has already been made of how var-
iations in Emi1 availability might explain different
responses to Cdk1 inhibition. In another example, we
may explain the re-replication caused by geminin deple-
tion in HCT116 cells [60-62] by assuming that Cdk and
the Cul4-Ddb1Cdt2 pathway play relatively minor roles, at
least in S-phase. The quantitative model of Cdk action can
be a useful way of viewing this: geminin is essential to
ensure TL<TF in such cells, whereas the Cul4-Ddb1Cdt2
pathway is not. Conversely, in HeLa cells, where depletion
of Cul4-Ddb1Cdt2 pathway causes re-replication [63,64],
the Cul4-Ddb1Cdt2 pathway is essential to ensure TL<TF,
whereas geminin is not.
Such explanations need to be tested in detail, but even if
they are true, difficult questions remain. Why, for exam-
ple, do HeLa cells appear to re-replicate when both gemi-
nin and cyclin A are depleted [60] when other
experiments [63,64] indicate that the Cul4-Ddb1Cdt2
pathway in HeLa cells should prevent this? Also, why is re-
replication seen after depletion of Emi1 or of geminin and
cyclin A [60,72], when these treatments are expected to
reset cells in a G1-like state and so cause endoreduplica-
tion, as seen after Cdk depletion [34,35,41,42]? There are
also technical issues concerning the methods for inactivat-
ing licensing control mechanisms and for measuring
responses. Is it possible, for instance, that the transient
and often incomplete nature of siRNA mediated depletion
could generate some misleading phenotypes, and how
reliable is flow cytometry as a method for distinguishing
endoreduplication and re-replication?
Clearly the scheme in Fig. 3 is just a working model and
further mechanisms, and/or links between them, are
likely to emerge. In fact cross-talk between mechanisms
Key regulators of over-replication higher eukaryotes Figure 3
Key regulators of over-replication higher eukaryotes. The relationships between Cdk, APC/C, geminin, Cul4-Ddb1Cdt2 
and Emi1 during different cell cycle phases are summarised. Me and Ml, early and late mitosis, respectively.
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has been proposed as way to ensure that disruption of just
one mechanism causes massive re-replication rather than
partial re-replication; the former would lead to apoptosis,
the latter to viable cells with genome damage that may
eventually threaten the whole organism [4]. To explore
such ideas, future work will require detailed comparisons,
both within a single cell system and between different cell
systems, of the effects of inhibiting each of the mecha-
nisms identified to date.
Conclusion
The quantitative model of Cdk action remains a useful
starting point for considering how DNA over-replication
is prevented, even in higher eukaryotes. Thus endoredu-
plication may be caused by procedures (e.g. Cdk inhibi-
tion or loss of APC/C inhibition) that flip the balance of
Cdk and APC/C activities from a Cdkhi/APClo state to a
Cdklo/APChi, G1-like state. In some systems this balance
may be delicately set, such that a single perturbation is
sufficient to promote endoreduplication, in others a com-
bination of perturbations may be required. Similarly, re-
replication may be caused by procedures that raise the
threshold of Cdk activity required to prevent origin licens-
ing above that required to promote origin firing. The bal-
ance of mechanisms that determine these thresholds
values is also likely to vary between cell systems such that
loss of one mechanism may be sufficient to cause re-repli-
cation in one system, whereas in other systems more that
one mechanism must be impaired. While these explana-
tions are consistent with many features of experimentally
induced over-replication, several inconsistencies remain
and these explanations will remain speculative until more
information, qualitative and quantitative, is obtained on
the various mechanisms that control origin licensing.
Cell lines
Cells referred to in this article (human, unless stated oth-
erwise): A549 (lung carcinoma), DT40 (Chicken B-cell),
FT210 (mouse mammary carcinoma with tsCdk1), HaCat
(keratinocyte), HCT116 (colon carcinoma), HeLa (cervi-
cal carconoma), Hep3B (liver carcinoma), HT1080 (fibro-
sarcoma), HT2-19 (HT1080 with IPTG-regulated Cdk1),
MEFs (mouse embryo fibroblasts), NCI-H1299 (non-
small cell lung cancer), MCF10A (immortalised breast
epithelial), Rat1 (rat 3T3-like fibroblasts), RKO (colon
carconoma), SaOS (osteosarcoma), SW480 (colon adeno-
carcinoma), TIG3 (normal diploid fibroblasts), U2OS
(osteosarcoma).
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